ウェビナー動画：Biotalys社、シングルドメイン抗体の研究開発をデジタル化・自動化する全工程対応のデータプラットフォーム

農学バイオテクノロジー専門のリーディング企業であるBiotalys社は、Genedataを活用し、作物保護を目的としたシングルドメイン抗体（sdAbs） の研究開発を効率化しています。本動画では、同社データ&インフォメーションマネージャーが登壇し、ワークフロー全体のデジタル化・自動化によって、sdAbsの創出とバイオプロセス開発を効率化するとともに、データインテグリティを確保している方法について紹介しています。

Dominique Vlieghe, Ph.D., Data and Information Manager, Biotalys, Ghent, Belgium

Discover how Biotalys uses a fully integrated workflow management and automation platform to increase efficiency and ensure data integrity during discovery and bioprocess development of single-domain antibodies (sdAbs). The Genedata Biopharma platform acts as Biotalys’ fully integrated central data and workflow management system for all critical R&D information and allows them to connect activities across discovery, development, and bioprocessing. By enabling instant information-sharing across projects and groups spanning high throughput screening, strain engineering (CLD), fermentation process (USP) development and analytics, and product purification (DSP), Genedata provides the key structured data foundation for decision-making and risk management.This enables Biotays to develop and manufacture groundbreaking biological products faster and in a more economically viable manner.

Learn how Biotalys uses Genedata Bioprocess to

• Increase operational efficiency of bioprocess development within and across USP, DSP, CLD, and bioanalytic teams.
• Obtain new insights from diverse stages of process development by analyzing all data and leveraging instant access to information.
• Enforce data quality, integrity, and compliance from early development through bioprocessing, facilitating submission of documents for new bioproduct certification and registration.
• Continuously optimize processes based on learnings from previous process development campaigns.
• Directly integrate with lab instruments to automate two-way data transfer, which increases efficiency and reduces manual errors.